It’s not often that a services provider gets a hefty venture capital investment. Last week, though, OpenStack cloud builder Mirantis raised $10 million. And today, Modus eDiscovery raised $10 million ...
Modus Therapeutics will present new research on sevuparin for chronic kidney disease (CKD) with anemia at the 32nd Symposium on Glycosaminoglycans, held 18–20 September at Villa Vigoni, Italy. The ...
New top line data has emerged from the company’s phase 1b study evaluating potential for treating sepsis New top line data has emerged from the company’s phase 1b study evaluating potential for ...
Modus Therapeutics presented data on sevuparin demonstrating its potential to treat anemia in chronic kidney disease at the annual American Society of Hematology (ASH) STOCKHOLM, SWEDEN – 11 December ...
WASHINGTON & SANTA MONICA, Calif.--(BUSINESS WIRE)--Aparavi®, a catalyst in data intelligence and automation software, and Modus, a leading provider of eDiscovery and Information Governance services, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback